Atypical antipsychotics as a possible treatment option for irritable bowel syndrome

Chi Un Pae, Soo Jung Lee, Changsu Han, Ashwin A. Patkar, Prakash S. Masand

    Research output: Contribution to journalReview articlepeer-review

    11 Citations (Scopus)

    Abstract

    Introduction: Irritable bowel syndrome (IBS) is a prevalent functional gastrointestinal disorder (FGID) that is characterised by chronic abdominal pain, discomfort, bloating, and alteration of bowel habits. Although the pathophysiology of IBS is not fully understood, it is believed that psychiatric comorbidities are highly common in such patients. A variety of psychotropic medications are widely used in the treatment of IBS, particularly older antidepressants such as tricyclic antidepressants (TCAs). Areas covered: With the advent of newer antidepressant classes with better safety and tolerability compared with TCAs, such as serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs), clinicians now have more advanced treatment options for treating IBS. Additionally, some atypical antipsychotics (AAs) have recently received approval for treatment of major depressive disorder (MDD). Some AAs may have potentials based on their pharmacodynamic profile and proven benefit for mood symptoms, pain, anxiety and sleep disturbances. This article describes the potential rationale, clinical data and practical aspects involved in the use of AAs for patients with IBS. Expert opinion: Atypical antipsychotics (AAs) may have a role in the treatment of irritable bowel syndrome (IBS) based on the currently available findings, although there is no clear evidence, and a number of clinical issues to be addressed in the use of AAs for the treatment of IBS.

    Original languageEnglish
    Pages (from-to)565-572
    Number of pages8
    JournalExpert Opinion on Investigational Drugs
    Volume22
    Issue number5
    DOIs
    Publication statusPublished - 2013 May

    Keywords

    • Anxiety
    • Atypical antipsychotic
    • Depression
    • Irritable bowel syndrome
    • Neurotransmitter

    ASJC Scopus subject areas

    • Pharmacology
    • Pharmacology (medical)

    Fingerprint

    Dive into the research topics of 'Atypical antipsychotics as a possible treatment option for irritable bowel syndrome'. Together they form a unique fingerprint.

    Cite this